| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192053 | Annals of Allergy, Asthma & Immunology | 2010 | 9 Pages |
Abstract
In this study, once-daily treatment with CIC-HFA 80 or 160 μg demonstrated statistically significant improvements in nasal and ocular symptoms of SAR. Both doses of active treatment were well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul MD, Robert MD, Dale MD, Holly MS, MPH, Shailesh Y. PhD, Joseph MD,